Rob Sheehan-Dare Leeds Centre for Dermatology

Slides:



Advertisements
Similar presentations
Detection and Treatment of Non-Melanoma Skin Cancers
Advertisements

Skin Pre-Cancer and Cancer
Precancers and Skin Cancers
SKIN CANCER DR D Czarnecki MD MB BS. Premalignant lesions Solar keratosesSolar keratoses SCC-in-situ (also called)SCC-in-situ (also called) Bowen’s disease.
SQUAMOUS CELL CARCINOMA
NonMelanoma Skin Cancer Dr David Burdon-Jones Consultant Dermatologist Dorset County Hospital Foundation Trust Interactive.
Skin Cancer Sarah Boyce Sawyer, MD Dermatology & Laser of Alabama.
Nonmelanoma Skin Tumor
Sajid Nazir How would you manage it? almost never metastasizes but it may kill by local invasion commonest skin cancer incidence is related to.
Skin Cancer What to look for and how to prevent it Emily Louise Keimig MS MD Clinical Instructor Department of Dermatology.
MALIGNANT EYELID TUMOURS
Basal Cell Carcinoma Presented by: Bill V. Way, D.O. AOCD Board Certified Dermatologist Residency in US Army at Walter Reed Consultant for Charlton Methodist.
Derm Lecture 4 Skin issues associated with systemic disease
Sun safety Lesley Pallett Workforce Health & Wellbeing Specialist Advisor and Ian Murray Dermatology Nurse.
Psoriasis & Skin Cancer
Skin Cancer Carlos Garcia MD Dermatology at OUHSC No conflicts of interest to disclose.
Psoriasis and Skin Cancer Edward Pritchard. Long Cases You could get these! Last year’s finals! - Patient with recurrent SCC, with no symptoms. History.
Skin Cancer BY: Taylor Lawrence. Description Skin Cancer- cancer that forms in the tissues of the skin Actinic Keratosis- This cancer is one of the most.
Your Skin J. C. DiGiacomo, M.D., FACS Department of Surgery CentraState Medical Center.
EPITHELIAL PRECANCEROUS SKIN LESIONS BY DR. MAHESH MATHUR MD.DVD,DCP
A Primer on Skin Cancers Cathryn Zhang, MD University of Arizona 3/8/14.
SKIN CANCER KARINA PARR, MD RONALD GRIMWOOD, MD KARA KENNEY.
Cutaneous Malignancies
Dermatopathology.
C&H Skin Cancer Referral Pathway 2013 Dr Sara Ritchie CCG GP Dermatology Lead.
DR. OLGA WATKINS November Outline Of Presentation Common Skin Lesions, Benign And Malignant Assessment Of Pigmented Lesion Points to take home.
PHOS-ISTOS D EVELOPMENT OF BIOPHOTONIC DEVICE BASED ON FLEXIBLE LIGHT EMITTING TEXTILE DEDICATED TO THE MONITORING AND TREATMENT FOR DERMATOLOGIC DISEASES.
FOH Presents… Skin Cancer
Skin Cancer Overview ; The Challenge of Diagnosing Older Patients Wendy E. Roberts MD.
Skin Cancer Skin cancer is the most common type of cancer
Dr. Saleem Shaikh NEOPLASIA - II. Majority of the neoplasms are categorised clinically and morphologically into benign and malignant on basis of certain.
Seborrheic Keratosis.
Skin tumors. Melanocytic naevi Melanocytic naevi are normal, benign proliferations of melanocytes. Although the risk of a naevus evolving into a melanoma.
 Neoplasms or tumors can be classified as benign or malignant  Benign = noncancerous  Malignant = cancerous.
November 13, 2007 Chapter: 31 Title: Noninfectious Diseases and Disabilities Lesson : 2 Title: Skin Cancer Grade Level: High school freshman health class.
Skin Cancer. What is cancer? The disease caused by a division of abnormal cells that are uncontrolled in the part of the body. Or a malignant growths or.
Cancer Invasive cellular neoplasm that has the capability of spreading throughout the body or body parts; uncontrolled cell growth.
CRYOSURGERY Pattippa Sumalai, M.D. Jutamas Tankunakorn, M.D. 23/09/2014.
Nonneoplastic epithelial disorders of vulva Women’s Hospital,School of Medicine Women’s Hospital,School of Medicine Zhejiang University Zhejiang University.
Skin Hazards from Sun Exposure Resource: cancer/ss/slideshow-sun-damaged-skin.
VULVA.
CLASSIFICATION OF CUTANEOUS MALIGNANCIES. 1- PREMALİGNANCİES (in situ) Actinic keratosis Actinic keratosis Bowen’s disease Bowen’s disease Lentigo maligna.
Photodynamic Therapy for Pre-cancerous lesions of the skin Alan Milligan Clinical Nurse Specialist for Non-Melanoma Skin Cancers.
MALIGNANT MELANOMA. Outline Introduction Aetiology Types Invasion and Metastasis Risk Factors Diagnosis and Staging Treatment and Prevention.
Skin Disorders  Cancer: rapid mitotic division of cells caused by a trigger environmental, genetic  Skin cancer: is caused by exposure to UV rays. There.
What’s new in the treatment of premalignant skin disease? Dr Caroline Morgan Poole Hospital NHS Foundation Trust December 3 rd 2015.
Skin cancer: Fundamentals of diagnosis and treatment Surgical training meeting, Worcester,6 th September 2017 Simon De Vos, FRCS MRCGP Specialty Dr,
“THE SKIN SHOW” Aging Dermatology and Disease Module #2
“Malignant skin tumors”
Intense Pulsed Light Alone in the Treatment of Actinic Keratosis
INFECTIONS Allergies, Fungal, Bacterial, Viral, Infection, Inflammation, and Genetic.
Skin Cancer Diagnoses and Treatments.
Seborrheic keratosis eyelid
Actinic keratoses after 4 weeks of treatment with 5-fluorouracil cream
Skin Pathology IV.
Ms Gabriella Da Ros Mr Ian Holten Australian Skin Face Body Clinics
Sun & Skin Dr Robin Pullen.
Actinic Keratosis.
Pathophysiology Unregulated cell growth and uncontrolled cell division result in the development of neoplasm.  Basal cell keratinization causes basal cells,
Dr Gillian Kyei GPwER Bromley Community Dermatology Service
Epithelial dysplasia → SCCIS → SCC
Human Papillomavirus Infection and Skin Cancer Risk in Organ Transplant Recipients  Jan N. Bouwes Bavinck, Mariet Feltkamp, Linda Struijk, Jan ter Schegget 
Lecture #2 Common Skin Lesions and Skin Malignancies
Imiquimod 5% cream monotherapy for cutaneous squamous cell carcinoma in situ (Bowen's disease): A randomized, double-blind, placebo-controlled trial 
Presentation transcript:

Rob Sheehan-Dare Leeds Centre for Dermatology Actinic Keratosis Rob Sheehan-Dare Leeds Centre for Dermatology

Pre-Cancerous Lesions Actinic Keratoses Intra-epithelial Squamous Cell Carcinoma Lentigo maligna Skin Cancer Basal Cell Carcinoma Squamous Cell Carcinoma Melanoma Lymphoma

What are Actinic keratoses? Epidermal dysplasia Associated with UV exposure Sun exposed sites Elderly Outdoor occupations Warmer climates Lighter skin types Immunosuppression

What are Actinic keratoses? Histologically Epidermal cell disorganisation Acanthosis Reduced granular layer Parakeratosis Hyperkeratosis

What is risk of malignancy? ?Less than 1:1000 per year Increased by Immunosuppression Increased numbers of lesions Co-factors (radiation, exposure to tar) Prior Squamous cell carcinoma Some lesions resolve spontaneously Most SCC’s are well differentiated

What do they look like? Clinically Adherent scale (variable but always) Erythema (often) Light pigmentation (sometimes) Merge with surrounding skin Usually not indurated

Diagnostic difficulties Cutaneous horn Hypertrophic actinic keratoses Inflammatory lesions Often in immunosuppressed

What to treat Lesions in immunosuppressed patients Lesions at high risk sites (e.g. lip) Where previous history of SCC Inflamed Actinic keratoses Lesions in younger age group Symptomatic lesions

How to treat Cryotherapy Curettage & cautery 5-fluorouracil cream Diclofenac gel Imiquimod cream Photodynamic therapy

Cryotherapy Destruction by cold injury Cotton bud or cryospray 20-30 second freeze Moderate pain Immediate blistering Heals in 10 days Suitable for small/few lesions Suitable where compliance poor

Curettage and cautery Physical removal/thermal injury Requires local anaesthesia Moderate pain Eschar Heals in 10 days Suitable for solitary/few lesions Suitable for cryo resistant lesions Suitable for hyperkeratotic lesions Suitable where histology required

5-fluorouracil cream Inhibits DNA synthesis by inactivating thymidine synthase 4 weeks treatment Inflammatory reaction (moderate-severe) Little pain Interrupted treatment may be required Suitable for multiple/extensive lesions Suitable for compliant patients

Diclofenac gel Inhibits Cyclo-oxygenase (COX-2) 8 weeks treatment Mild-moderate inflammatory reaction No pain Long term benefits uncertain Suitable where intolerance to other treatment

Imiquimod cream Toll-like receptor 7 agonist induces apoptosis 4-8 weeks treatment Inflammatory reaction (moderate-severe) Little pain Interrupted treatment may be required Suitable for multiple/extensive lesions Suitable for compliant patients

Photodynamic therapy ALA induced protoporphyrin IX synthesis sensitizes cells to photodynamic effect 1-2 prolonged treatments Moderate pain Inflammatory reaction (moderate-severe) Heals in 10 days Suitable for multiple/extensive lesions Suitable where compliance poor

Treatment summary Cryotherapy small/few lesions 5-fluorouracil larger/multiple lesions Curettage for hyperkeratotic lesions Solaraze for patients with poor tolerance Imiquimod cream or PDT for resistant lesions

“They look benign , but keep out of the sun”